Ovarian Cancer Project Inc (EIN 461013307) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2012

Legal Domicile

Phone

7169466437

Tax Period

2024-01-01 to 2024-12-31

Ovarian Cancer Project Inc, founded in 2012, is a small nonprofit in the Diseases & Disorders sector that reported $180K in total revenue in fiscal year 2024. Revenue grew 19% year-over-year, indicating healthy expansion. Expenses of $172K left a modest 5% surplus.

Mission

OUR MISSION IS TO EDUCATE THE WNY COMMUNITY ON THE SYMPTOMS AND RISKS OF OVARIAN AND ALL GYNECOLOGIC CANCER, AND TO PROVIDE SUPPORTIVE SERVICES TO SURVIVORS AND THEIR FAMILIES EXPERIENCING THESE CANCERS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $122,307

Program Service Revenue $0

Investment Income $11,122

Other Revenue $47,037

TOTAL REVENUE $180,466

Expense Breakdown

Grants Paid $0

Salaries & Benefits $58,741

Fundraising Expenses $873

Program Expenses $54,459

Other Expenses $113,537

TOTAL EXPENSES $172,278

Year-over-Year Comparison

	2024	2023	Change
Revenue	$180,466	$151,713	+0.2%
Expenses	$172,278	$95,400	+0.8%
Net Income	$8,188	$56,313	-0.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$54,916

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Marianne Hoover	Executive Dir.	40.00	Officer	$54,916	$0	$54,916
Maria Colon CRT	Vice President	2.00	Director	$0	$0	$0
Bridget Hallock Kasaoka	Director	2.00	Director	$0	$0	$0
Laurel Oliver	Director	2.00	Director	$0	$0	$0
Kathleen Maxian	Board Trustee	2.00	Director	$0	$0	$0
Vicky Marie Brunette	President	5.00	Officer	$0	$0	$0
Bobbi Levine	Treasurer	5.00	Officer	$0	$0	$0
Julie Tiao	Secretary	5.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$180,466	$172,278	$344,264	$8,188
2023	$151,713	$95,400	$321,472	$56,313
2022	$85,701	$67,737	$264,837	$17,964
2021	$66,479	$52,461	$247,272	$14,018
2020	$74,975	$49,059	$236,422	$25,916
2019	No data	No data	No data	No data
2019	$160,939	$43,003	$203,773	$117,936
2018	$53,721	$42,583	$87,827	$11,138

Ovarian Cancer Project Inc